After surgery, the MMP-13 level decreases and, when raising again, can predict an invasive SCC and lymph node metastasis; thus MMP-13 can represent a reliable biomarker for invasiveness and tumor progression monitoring (90). The gene discussed is MMP13; the disease is metastatic malignant neoplasm in the lymph nodes.